Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient

Abstract

View all access options for this article.

Mehling

Brinkmann

Antel

. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology 2008; 71: 1261–1267.

Cohen

Barkhof

Comi

.; TRANSFORMS Study Group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010; 362: 402–415.

Gkolfinopoulou

Bitsolas

Patrinos

. Epidemiology of human leishmaniasis in Greece, 1981–2011. Euro Surveill 2013; 18: 20532.

Wilson

Jeronimo

Pearson

. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 2005; 38: 147–160.

M Opata

Stephens

. Early decision: Effector and effector memory T cell differentiation in chronic infection. Curr Immunol Rev 2013; 9: 190–206.